skip to main content
Refinado por: Nome da Publicação: Bmc Gastroenterology remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Body Mass Index, sex, non-steroidal anti-inflammatory drug medications, smoking and alcohol are differentially associated with World Health Organisation criteria and colorectal cancer risk in people with Serrated Polyposis Syndrome: an Australian case-control study
Material Type:
Artigo
Adicionar ao Meu Espaço

Body Mass Index, sex, non-steroidal anti-inflammatory drug medications, smoking and alcohol are differentially associated with World Health Organisation criteria and colorectal cancer risk in people with Serrated Polyposis Syndrome: an Australian case-control study

Anthony, Emma ; Reece, Jeanette C ; Milanzi, Elasma ; Joo, Jihoon E ; Joseland, Sharelle ; Clendenning, Mark ; Whelan, Amanda ; Parry, Susan ; Arnold, Julie ; Vijay, Varnika ; Atkinson, Nathan ; Hopper, John L ; Win, Aung K ; Jenkins, Mark A ; Macrae, Finlay A ; Winship, Ingrid M ; Rosty, Christophe ; Buchanan, Daniel D

BMC gastroenterology, 2022-11, Vol.22 (1), p.489-16, Article 489 [Periódico revisado por pares]

England: BioMed Central Ltd

Texto completo disponível

2
Hemorrhagic cholecystitis with rare imaging presentation: a case report and a lesson learned from neglected medication history of NSAIDs
Material Type:
Artigo
Adicionar ao Meu Espaço

Hemorrhagic cholecystitis with rare imaging presentation: a case report and a lesson learned from neglected medication history of NSAIDs

Zhang, Xin ; Zhang, Chunjun ; Huang, Haifeng ; Wang, Junsen ; Zhang, Yun ; Hu, Qida

BMC gastroenterology, 2020-06, Vol.20 (1), p.172-5, Article 172 [Periódico revisado por pares]

England: BioMed Central Ltd

Texto completo disponível

3
Treatment with pirfenidone for two years decreases fibrosis, cytokine levels and enhances CB2 gene expression in patients with chronic hepatitis C
Material Type:
Artigo
Adicionar ao Meu Espaço

Treatment with pirfenidone for two years decreases fibrosis, cytokine levels and enhances CB2 gene expression in patients with chronic hepatitis C

Flores-Contreras, Lucia ; Sandoval-Rodríguez, Ana S ; Mena-Enriquez, Mayra G ; Lucano-Landeros, Silvia ; Arellano-Olivera, Inmaculada ; Alvarez-Álvarez, Arnulfo ; Sanchez-Parada, M Guadalupe ; Armendáriz-Borunda, Juan

BMC gastroenterology, 2014-07, Vol.14 (1), p.131-131, Article 131 [Periódico revisado por pares]

England: BioMed Central

Texto completo disponível

4
Increased proton pump inhibitor and NSAID exposure in irritable bowel syndrome: results from a case-control study
Material Type:
Artigo
Adicionar ao Meu Espaço

Increased proton pump inhibitor and NSAID exposure in irritable bowel syndrome: results from a case-control study

Keszthelyi, Daniel ; Dackus, Gwen H ; Masclee, Gwen M ; Kruimel, Joanna W ; Masclee, Ad A M

BMC gastroenterology, 2012-09, Vol.12 (1), p.121-121, Article 121 [Periódico revisado por pares]

England: BioMed Central Ltd

Texto completo disponível

5
Combination therapy of infliximab and thalidomide for refractory entero-Behcet's disease: a case report
Material Type:
Artigo
Adicionar ao Meu Espaço

Combination therapy of infliximab and thalidomide for refractory entero-Behcet's disease: a case report

Li, Yue ; Han, Zelong ; Wang, Xianfei ; Mo, Zhihui ; Zhang, Wei ; Li, Aimin ; Liu, Side

BMC gastroenterology, 2013-12, Vol.13 (1), p.167-167, Article 167 [Periódico revisado por pares]

England: BioMed Central Ltd

Texto completo disponível

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Buscando em bases de dados remotas. Favor aguardar.